Facilitating Shared Decisionmaking About Prostate Cancer Screening
Background:
Due to the disputed efficacy of prostate cancer (CaP) screening and treatment, most
authorities recommend that providers inform and involve patients in CaP screening decisions.
Objectives:
This study evaluated two interventions designed to facilitate this process.
Methods:
1152 male veterans age 50+ with no CaP and primary care appointments at four VA medical
facilities in VISN 23 were randomly assigned to one of three groups: mailed pamphlet
intervention, mailed video intervention, or usual care (control). Intervention materials
were mailed two weeks prior to a target primary care appointment and patient telephone
surveys were conducted one week (T1) and one year (T2) after the target appointment.
Outcomes included: a 10- item validated knowledge index; responses to questions on CaP
natural history, treatment efficacy, PSA accuracy, and expert disagreement about the PSA;
whether screening was discussed with provider; scores on decision information seeking,
participation and satisfaction scales; screening and treatment preferences; and PSA testing
rates.
Status:
Complete
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Treatment
Melissa R. Partin, PhD
Principal Investigator
Department of Veterans Affairs
United States: Federal Government
IIR 99-277
NCT00013247
December 2002
Name | Location |
---|---|
Minneapolis VA Medical Center | Minneapolis, Minnesota 55417 |